|
ATP2B4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.99850000004442E-06 |
| Normal-vs-Stage3 |
5.4648999769924E-09 |
| Normal-vs-Stage4 |
1.6311000328173E-09 |
| Stage1-vs-Stage2 |
3.759200E-01 |
| Stage1-vs-Stage3 |
9.309600E-01 |
| Stage1-vs-Stage4 |
1.692160E-01 |
| Stage2-vs-Stage3 |
5.470000E-01 |
| Stage2-vs-Stage4 |
8.414800E-01 |
| Stage3-vs-Stage4 |
3.429800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.206640E-04 |
| Normal-vs-Asian |
1.976210E-04 |
| Caucasian-vs-AfricanAmerican |
3.938300E-02 |
| Caucasian-vs-Asian |
8.010800E-01 |
| AfricanAmerican-vs-Asian |
2.377200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62581059726108E-12 |
| Normal-vs-Female |
9.06164032699053E-13 |
| Male-vs-Female |
6.829000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.64050000000171E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62914126633495E-12 |
| Normal-vs-Age(61-80Yrs) |
1.72317715652071E-12 |
| Normal-vs-Age(81-100Yrs) |
8.216900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.591000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.288000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.627200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.988000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.829000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.368800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.36420002755978E-09 |
| Normal-vs-Grade 2 |
1.62447832963153E-12 |
| Normal-vs-Grade 3 |
2.68640665268549E-12 |
| Normal-vs-Grade 4 |
1.19139997867279E-09 |
| Grade 1-vs-Grade 2 |
1.846810E-01 |
| Grade 1-vs-Grade 3 |
2.222400E-02 |
| Grade 1-vs-Grade 4 |
3.939800E-02 |
| Grade 2-vs-Grade 3 |
4.194000E-02 |
| Grade 2-vs-Grade 4 |
2.470200E-01 |
| Grade 3-vs-Grade 4 |
7.661000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.11022302462516E-16 |
| Normal-vs-ccB subtype |
2.10564898850407E-12 |
| ccA subtype-vs-ccB subtype |
7.936200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6503465261053E-12 |
| Normal-vs-N1 |
7.190000E-02 |
| N0-vs-N1 |
3.974400E-01 |
|
|
